Join us this Friday, the 15th of March 2024 as Dr. Tobi Nagel discusses Bacteriophages: An Important Tool to Help Combat the Antibiotic Resistance Crisis. The World Health Organization states that Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. This discussion will focus on how bacteriophages can help.

Dr. Tobi Nagel is Founder and President of Phages for Global Health, a non-profit facilitating the application of antibacterial phages to combat antibiotic resistance in developing countries. Tobi spent 15 years in the pharmaceutical industry co-developing drugs that have been tested in >80 clinical trials. She was a Moonshot Fellow of the Kravis Lab for Social Impact, a Fulbright Specialist roster member, an Advisor to Phages for Human Applications Group Europe, a Scientific Consultant for Global Strategies for HIV Prevention and CRDF Global, and a founding Editorial Board member of the scientific journal PHAGE. She is currently an Advisory Board member for both the Phagebiotics Research Foundation and PhagePro, a company developing cholera phages. Tobi did a Postdoctoral Fellowship at the American Hospital in Turkey and completed a PhD in Medical Engineering at the Harvard-MIT Division of Health Sciences and Technology and a BS in Chemical Engineering at Stanford University.